RenovoRx (RNXT) Earnings Analysis

RenovoRx (RNXT) next reports earnings on 2026-08-13, consensus EPS -0.08 USD. Last quarter (2026-05-14) it beat with EPS -0.08 USD vs -0.08 USD est (0%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -2.58.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does RNXT next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.08 USD
Revenue estimate0.00B

RNXT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.08 USD-0.08 USD0%Beat
2026-03-30-0.08 USD-0.08 USD0%Beat
2025-11-13-0.08 USD-0.08 USD0%Beat
2025-08-14-0.08 USD-0.08 USD0%Beat
2025-05-15-0.08 USD-0.08 USD0%Beat
2025-03-31-0.12 USD-0.13 USD+7.7%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

RNXT valuation and analyst view

Trailing P/E-2.58
Trailing EPS-0.32259 USD
Price / book2.92
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (4 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is RenovoRx (RNXT)'s next earnings date?

RenovoRx is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.08 USD and revenue estimate of 0.00B.

Did RNXT beat earnings last quarter?

In its 2026-05-14 report, RNXT posted EPS of -0.08 USD versus a -0.08 USD estimate — a beat of 0%.

What is RNXT's earnings track record?

Over the last 6 reported quarters with consensus data, RNXT beat estimates 6 times (100%).

What is RNXT's current P/E ratio and EPS?

RNXT trades at a trailing P/E of -2.58 on trailing EPS of -0.3225931896368101 USD.

What do analysts rate RNXT?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell).